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Purpose: To develop an assay that can enable the quantifica-
tion of intra- and extracellular nitric oxide (NO) levels in liver
biopsies without application of potentially harmful exogenous
NO traps.
Theory: Electron paramagnetic resonance (EPR) spectroscopy
is currently the most appropriate method of measuring NO in
biological samples due to the outstanding specificity resulting
from the interaction of NO with exogenous NO traps. Because
such traps are not allowed in clinical settings, we tested the
reliability of endogenous NO traps for the determination of NO
levels in blood and liver compartments.
Methods: Rats were injected with 0–8 mg/kg lipopolysaccha-
ride (LPS) to gradually induce a systemic inflammatory
response. Specific features of NO-hemoglobin and NO–Fe EPR
signals were quantified using a specifically developed calibra-
tion procedure.
Results: Whereas both NO–hemoglobin (NO–HbLIVER BLOOD) and
NO–Fe (NO–FeLIVER) complexes were detected in nonperfused liver
tissue, only NO–Fe complexes were detected in perfused tissue and
only NO–Hb complexes were detected in blood (NO–HbBLOOD). The
NO concentrations increased in the sequence NO–HbBLOOD<NO–
FeLIVER<NO–HbLIVER BLOOD (9.4, 18.5, 27.9 nmol/cm3, respectively
at 2.5 mg/kg LPS). The detection limit of the method was 0.61
nmol/cm3 for NO–Hb and 0.52 nmol/cm3 for NO–Fe.
Conclusion: The assay reported here does not influence natural
NO pathways and enables the quantification of NO distribution in
two liver compartments using a single liver biopsy. Magn Reson
Med 77:2372–2380, 2017. VC 2016 International Society for
Magnetic Resonance in Medicine
Key words: endogenous NO traps; mononitrosyl-hemoglobin
complex; dinitrosyl–iron complex; nitric oxide; electron para-
magnetic resonance
INTRODUCTION
Nitric oxide (NO) is a powerful signaling molecule that
regulates some of the most fundamental physiological
processes in living organisms, including vascular tone,
neurotransmission, host defense systems, and others (1).
In mammals, NO is synthesized by a family of enzymes
called NO synthases (NOS; EC 1.14.13.39), which
includes three isoforms: the constitutively expressed neu-
ronal NOS (NOS I), endothelial NOS (NOS III), and induc-
ible NOS (NOS II). All three isoforms convert L-arginine to
L-citrulline and NO in the presence of oxygen.
Neuronal NOS is expressed predominantly in specific
neurons of the central nervous system. It regulates gut
peristalsis, vasodilation, and penile erection, acts as an
atypical neurotransmitter, and has been suggested to par-
take in memory formation and learning [reviewed by
Forstermann and Sessa (2)].
Expression of inducible NOS can be activated by cyto-
kines and other molecules and is crucial for many proc-
esses in various cell types, such as defense against
bacteria in macrophages (3,4). In addition, the up-
regulation of inducible NOS occurs in response to in-
flammation in both parenchymal cells and cells within
the blood compartment, implicating several symptoms
that are mediated by NO (5).
Endothelial NOS is expressed mostly in endothelial
cells (2) but was also found in cardiac myocytes, plate-
lets, specific neurons in the brain, syncytiotrophoblasts
in human placenta, and a kidney tubular epithelial cell
line [reviewed by Forstermann and Sessa (2)].
An additional pathway of NO formation is the reduc-
tion of nitrite by a group of enzymes called nitrite reduc-
tases, which, in contrast to NOS, exert higher activity
under hypoxia (6). Nitrite reductases are heme proteins
located in the blood compartment (hemoglobin [Hb] in
red blood cells [RBCs]) and in parenchymal cells of tis-
sues (mitochondria, myoglobin, xanthine oxidoreductase)
(6,7). This source of NO is associated with cytoprotective
effects and regulation of hemodynamics (6,7).
In general, NO is considered a physiological messen-
ger. However, in addition to physiological functions, NO
may be deleterious due to NO-mediated modification of
proteins, induction of neurotoxicity, inhibition of mito-
chondrial respiration, and organelle fragmentation (8).
The majority of deleterious effects of NO are associated
with the formation of peroxynitrite, a product of the
interaction between NO and superoxide. Peroxynitrite
formation is typical for immune cells, which are able to
destroy microorganisms using the very reactive nature of
this molecule (9). NO generated by immune cells in the
blood contributes to killing of bacteria and can also
cause damage to the host. A part of NO produced in
blood is trapped by Hb-forming mononitrosyl–
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hemoglobin complexes (NO–Hb) (10); another part of NO
reacts with oxyhemoglobin and is oxidized to nitrate
(11). In contrast, NO produced inside the cells forms pre-
dominantly dinitrosyl–iron complexes (NO–Fe) (12). In
blood plasma, however, there are no ferrous ions (Fe2þ),
because they are oxidized by ceruloplasmin and subse-
quently bound to transferrin. This suggests that these
two NO-related signals (NO–Hb and NO–Fe) provide
information about intra- and extracellular NO production
in organs.
Because the preparation/homogenization of tissue may
result in changes of NO levels, we used unprocessed
shock frozen liver biopsies which were analyzed by
means of low temperature (liquid nitrogen) electron para-
magnetic resonance (EPR) spectroscopy.
METHODS
Chemicals
All chemicals were obtained from Sigma-Aldrich (Vienna,
Austria) unless noted otherwise.
Animals
The in vivo experiments were performed on male
Sprague–Dawley rats (n¼45; weight, 250–300/390–
540 g; Animal Research Laboratories, Himberg, Austria/
Charles River, Germany) which were kept under con-
trolled standard animal housing conditions. The animals
had free access to standard laboratory rodent food and
water. They were kept for 7 days prior to usage in
experiments for accommodation. All interventions were
conducted in compliance with the National Institutes of
Health’s “Guide for the Care and Use of Laboratory Ani-
mals” with approval from the Animal Protocol Review
Board of the city government of Vienna, Austria.
Lipopolysaccharide Treatment
Lipopolysaccharide (LPS) from Escherichia coli serotype
026:B6 (activity 500,000 EU/mg) was used for the dose-
dependence experiments. Six groups of rats were
injected with various doses (0.2, 1.3, 2.5, 4.7, 6.3, and
8.5 mg/kg body weight) of LPS dissolved in saline (Fre-
senius Kabi, Bad Homburg vor der H€ohe, Germany). Con-
trol animals were injected with saline only. Samples
were collected 16 h after LPS injection.
In a separate set of experiments, animals were divided
into five groups. All rats were injected with the same dose
of LPS (Escherichia coli serotype 026:B6, 8 mg/kg body
weight, activity 10,000 EU/mg) dissolved in saline, and
samples were taken 2, 4, 8, and 16 h after LPS treatment.
Control animals were injected with saline only.
The LPS solution was vortexed for 1 min and soni-
cated for 30 s before application, and subsequently
injected in the penis vein under isoflurane anaesthesia
in a volume ranging from 0.5 to 0.75 mL.
Design of Animal Experiments and Sampling
of Blood and Liver Tissue
In order to prevent unnecessary pain, buprenorphine
(Richter Pharma AG, Wels, Austria, 0.05 mg/kg body
weight) was injected subcutaneously at the time of LPS
treatment and 10 h thereafter.
At the end of the treatment phase with LPS, or to
obtain samples for control and calibration purposes, rats
were anesthetized via inhalation of a mixture of 3% iso-
flurane and oxygen. After a small skin cut, the left femo-
ral artery was dissected and catheterized using a 24-
gauge intravenous cannula (BD Neoflon; Becton Dickin-
son Infusion Therapy AB, Helsingborg, Sweden). A total
of 10–12 mL whole blood was collected in a 50-mL
Falcon tube prefilled with 200 mL of sodium heparin
(1000 IU/mL; Gilvasan Pharma GmbH, Vienna, Austria)
for subsequent processing and for the in vitro part of the
study.
For determination of the NO–Hb level, blood samples
were taken into Minicollect tubes coated with lithium
heparin (Greiner Bio-One GmbH, Kremsm€unster, Aus-
tria). After centrifugation at 4 C and 1600 g for 10 min,
the plasma was removed and the erythrocyte pellet was
collected in 1-mL plastic syringes and subsequently
shock-frozen in liquid nitrogen for storage at 80 C
until EPR measurement.
Following the blood sampling, the animals were killed
via decapitation. Subsequently, the liver was excised
and transferred immediately to a beaker filled with ice-
cold Ringer solution (Fresenius Kabi AG, Bad Homburg
vor der H€ohe, Germany). After cooling down, the liver
was cut into small pieces on a Petri dish placed on ice.
Tissue samples to a volume of 0.4 mL were filled in
1-mL plastic syringes and shock-frozen in liquid nitrogen
and stored at 80 C for further measurements.
Preparation of Blood and Liver Calibration
Samples for EPR
Calibration samples were prepared separately from blood
and liver of LPS-untreated animals. For the isolation of
blood and liver tissue, the rats were anesthetized as
described above and killed via decapitation. Blood (10–
15 mL) was collected into a 50-mL Falcon tube that was
prefilled with 200 mL of sodium heparin (1000 IU/mL;
Gilvasan Pharma GmbH, Vienna, Austria) and placed on
ice for cooling. Subsequently, the liver was perfused in
situ through the portal vein and inferior caval vein, with
ice-cold Ringer-sodium heparin solution (0.8 IU sodium
heparin/mL Ringer solution) until the effluent solution
contained no more blood. After perfusion, the liver was
transferred to ice cold Ringer solution.
Collected erythrocytes and liver were used to prepare
hemolysates and homogenates, respectively. In order to
isolate the RBCs, collected blood was washed twice with
ice-cold saline (0.9%), centrifuged at 4C and 1600 g for
10 min, and separated from supernatant. RBCs were
diluted 1:2 with double distilled water and homogenized
using an overhead stirrer (RW16, IKA Werke, Staufen im
Breisgau, Germany). The concentration of heme in the
RBC-hemolysate was determined on the basis of spectro-
photometric measurements (350–600 nm; UV-1800, Shi-
madzu, Kyoto, Japan) and the Soret band corresponding
to deoxyhemoglobin. For the preparation of liver
homogenates, approximately 2 g of liver tissue were
homogenized 1:3 with ice-cold saline (0.9%).
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Preparation of NO–Hb and NO–Fe Complexes
for EPR Calibration
EPR samples for NO–Hb and NO–Fe calibration curves
were prepared either from RBC–hemolysate or liver
homogenate. For NO–Hb calibration, the samples for the
calibration curve were prepared in two different ways,
resulting in two independent calibration curves. One of
these sample series was prepared by mixing hemolysate to
final concentrations of heme ranging from 1 to 150 mM
and NaNO2 to a final concentration of 1 M. The second
sample series was prepared by mixing hemolysate to a
final concentration of 5 mM with NaNO2 to final concen-
trations in a range of 1–150 mM. Regardless of preparation
procedure, each sample was prepared in a volume of 500
mL with 50 mg of Na2S2O4 to remove the bound oxygen
from heme and reduce NaNO2 to NO. The samples for cali-
bration curve of NO–Fe were prepared by mixing liver
homogenate with Fe(II)SO4 (final concentration, 1–150
mM) and NaNO2 (concentration, 1 M) to a final volume of
500 mL. Calibration samples were subsequently filled in
1-mL plastic syringes, shock-frozen in liquid nitrogen and
stored at 80C for further measurements.
EPR Measurements
EPR spectra were recorded at liquid nitrogen temperature
(196C) with a Magnettech MiniScope MS 200 EPR
spectrometer (Magnettech, Berlin, Germany) in a quartz
finger-type Dewar flask filled with liquid nitrogen. The
EPR spectra were recorded at short- and long-scale
ranges. The general settings for a short range were as fol-
lows: modulation frequency, 100 kHz; microwave fre-
quency, 9.425 GHz; microwave power, 8.3 mW;
modulation amplitude, 5 G; and gain, 200. NO–Hb
complexes were recorded at 33006200 G. The general
settings for long range were as follows: modulation
frequency, 100 kHz; microwave frequency, 9.429 GHz;
microwave power, 30 mW; and modulation amplitude,
6 G. Liver spectra were recorded at 32006 500 G. The
spectra were quantified by the determination of magni-
tudes of different components of spectra and by double
integration of EPR spectra.
FIG. 1. Complete traces showing the changes in EPR spectra of liver samples obtained from control rats (S1) and from rats 2 (S2), 4
(S3), 8 (S4), and 16 (S5) h after LPS challenge (a). The enlarged section of these EPR spectra (c) shows two peaks (g¼2.075 and
g¼2.042) increasing in a time-dependent manner. The peak observed at g¼2.075 increased within the time frame of 2–8 h (S2–S4),
whereas the peak observed at g¼2.042 began to increase only after 16 h (S5). To identify these signals, the corresponding full length
(b) or an enlarged cutout (d) of these liver spectra were plotted together with EPR spectra of model mononitrosyl–hemoglobin (NO–Hb,
S8) and dinitrosyl–iron (NO–Fe, S9) complexes occurring at the same g-factors. Compared with these very clear spectra, those obtained
from sham-operated animals (S6) and animals challenged with 6.3 mg/kg body weight of LPS for 16 h (S7) showed NO–Hb and NO–Fe
signals that overlapped with other naturally occurring liver signals. These samples were prepared from either hemolysate or liver homog-
enate as described in the Methods. Abbreviations: AMP, amplitude; g, g-factor; S, signal.
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Data Presentation and Statistical Analysis
Statistical evaluation of data was performed using
GraphPad Prism 5.01 for Windows (GraphPad Software,
La Jolla, California, USA). Statistical significance of cor-
relations was analyzed using Pearson’s test.
RESULTS
EPR spectra of rats challenged with LPS showed an
increase in the intensity of two peaks located at
g¼ 2.075 and g¼ 2.042 (Fig. 1). The signal observed at
g¼ 2.075 was already elevated significantly between 2
and 8 h after LPS challenge (Fig. 1a and 1c, S2–S4),
whereas the signal at g¼ 2.042 rose only after 16 h after
challenge. These signals were identified on the basis of
their comparison with the model NO–Hb (Fig. 1b and
1d, S8) and NO–Fe (Fig. 1b and 1d, S9) complexes. In
Figure 1b and 1d, EPR signals of model complexes were
compared with signals observed in healthy animals (Fig.
1b and 1d, S6) and 16 h after LPS challenge (Fig. 1b and
1d, S7). In the spectrum of liver tissue, both signals over-
lap with other naturally occurring liver signals. The sub-
traction of the signal observed in healthy animals (Fig.
1b and 1d, S6) from the signal observed in animals chal-
lenged for 16 h with LPS (Fig. 1b and 1d, S7) leads to a
decrease in both NO–Hb and NO–Fe peaks, thus enhanc-
ing the overlapping with naturally occurring signals
(Supporting Fig. S1). To find the optimum means of esti-
mating the intensity of NO–Hb and NO–Fe signals,
model signals of both species were analyzed.
NO–Hb signals were generated as a function of Hb
concentration in the presence of an NO excess (Fig. 2).
Different parameters of the spectrum were used to esti-
mate the intensity of this signal: amplitude 1 (AMP1),
amplitude 2 (AMP2), amplitude 3 (AMP3), and the dou-
ble integral (DI). AMP1 and DI reflect both 5- and 6-
coordinated NO–Hb complexes, while AMP2 corre-
sponds to 5-coordinated heme iron and AMP3 to
6-coordinated heme iron, respectively. All four parame-
ters showed linear correlation with Hb concentrations,
suggesting that any of these parameters can be used for
quantification of NO–Hb.
A similar picture was observed when an excess of Hb
was treated with increasing concentrations of NaNO2.
Similarly, all four parameters showed a linear correlation
with NO (nitrite) levels (Fig. 3). AMP1 slopes were simi-
lar in both cases. Because NO–Hb signal is generally rep-
resented by a sum of signals of 5- and 6-coordinated
heme iron, the shape of the signals was analyzed. Thus,
we calculated the ratio between the magnitudes (AMP1,
AMP2, and AMP3) and DI, representing both complexes.
Figure 4 clearly shows that the shape of the signals
does not change with increasing concentration of com-
plexes, suggesting a constant ratio of 5- to 6-coordinated
forms of Hb in the samples.
NO–Fe signals were generated and analyzed in the
same manner (Fig. 5). This procedure must be performed
in the natural tissue environment, because the shape and
the position of the NO–Fe signal in the EPR spectrum
depends on the nature of proteins donating SH groups to
FIG. 2. Calibration of NO–Hb using 1–150 mM Hb, 1 M nitrite, and 50 mg dithionite per sample. The typical EPR spectra recorded in NO–Hb
calibration samples (a) provide four different quantitative parameters that can be used for the quantification of NO–Hb: AMP1, AMP2, AMP3,
and the DI. The concentration of Hb and intensity of NO–Hb signal, which was calculated based on AMP1 (b), AMP2 (c), AMP3 (d), and DI
(e), show a strong positive correlation. This was observed in case of all quantitative parameters of the spectrum, indicating that any of these
parameters can be used for quantification. Abbreviations: AMP, amplitude; m, slope; r, coefficient of determination.
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form dinitrosyl–iron complexes. Therefore, liver homoge-
nate was used for this calibration procedure. Liver
homogenate, however, contains many other substances
reacting with NO apart from Fe2þ. Consequently, the cal-
ibration of this signal using increasing NO levels was not
possible, because a significant part of NO was trapped
FIG. 3. Calibration curve for NO–Hb prepared using increasing nitrite (NaNO2) concentrations (1–150 mM), 5 mM hemoglobin (Hb) and
50 mg dithionite per sample. We determined AMP1 (a), AMP2 (b), AMP3 (c), and the DI (d) of the NO–Hb signal as shown in Figure 2.
Nitrite concentrations and intensity of NO–Hb signals show a strong positive correlation in case of all four quantitative parameters.
Abbreviations: AMP, amplitude; m, slope; r, coefficient of determination.
FIG. 4. Correlations between the NO–Hb quantification parameters provided by NO–Hb calibration based on variation in concentration
of Hb (a–c) and nitrite (d–f) in the range of 1 to 150 mM. Strong correlations between AMP1 (a, d), AMP2 (b, e), AMP3 (c, f), and the DI
indicate that the shape of the signal does not change at various concentrations of NO–Hb, regardless of whether Hb or nitrite concen-
trations were varied. Abbreviations: AMP, amplitude; m, slope; r, coefficient of determination.
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by other species than Fe2þ (data not shown). To over-
come this limitation, a different approach was necessary.
For this, the signal was calibrated with increasing Fe2þ
concentrations in the presence of an excess of NO, simi-
larly to the calibration of NO–Hb signal with increasing
Hb concentrations. This method delivered clear NO–Fe
signals (Fig. 5a), which were analyzed by determining
the intensity (amplitude, AMP) and the DI (Fig. 5). Both
parameters showed a strong correlation with Fe2þ con-
centrations as well as with each other.
To quantify NO–Hb and NO–Fe in liver tissue, the
magnitudes of parameter AMP1 of NO–Hb signal and
parameter AMP of NO–Fe signal were chosen because
they were the most distinguishable in the complex EPR
spectrum of the liver. These selected parts of signals and
the corresponding calibration curves were used to deter-
mine intra- and extracellular NO concentrations in liver
and circulating arterial blood of animals subjected to
bacterial endotoxin (Fig. 6b). NO–Hb in blood and NO–
Fe in liver correlated with the LPS doses (Fig. 6c–6e).
Furthermore, all three parameters correlated well with
each other (Figure 6f–6h).
The signal-to-noise ratio is a measure of the sensitivity.
Absolute sensitivity threshold is commonly defined as a
concentration of a substance needed to get a signal equiva-
lent to the noise observed in the spectrum. However, in
our samples, the minimal signal-to-noise ratio allowing
the evaluation of NO-related signals in liver biopsies was
3. On the basis of this value, we determined the sensitivity
of the method for NO–Fe and NO–Hb complexes. We
assessed the instrumental noise by measuring its ampli-
tude in sections of spectra where no specific signal was
present. Detection limit of the method is 0.61 nmol/cm3
for NO–Hb and 0.52 nmol/cm3 for NO–Fe.
DISCUSSION
Here we demonstrate the possibility of determining levels
of NO generated in blood and tissue compartments of liver
in a single liver biopsy. This method is based on the fact
that Hb, a strong scavenger of NO, is located exclusively in
blood, and that blood plasma does not contain free Fe2þ,
because in blood they are all oxidized by ceruloplasmin
and bound to transferrin (Fig. 7). In contrast, parenchymal
cells (eg, hepatocytes) contain Fe2þ but do not contain Hb.
Consequently, NO occurring in blood will be trapped by
Hb yielding NO–Hb complexes, whereas NO generated
inside the liver cells will be bound to Fe2þ to form NO–Fe
complexes. Both complexes have distinct EPR spectra (Fig.
1b and 1d, S8 and S9). Hepatocytes contain certain
amounts of heme proteins, which theoretically can form
NO–Hb complexes, thus limiting the method described
here. However, our experiments showed that liver per-
fused with Ringer’s solution displays an NO–Fe signal
FIG. 5. Calibration of NO–Fe using 1 to 130 mM Fe(II)SO4 and 1 mM nitrite in liver homogenate. The EPR spectra recorded in such NO–
Fe calibration samples (a) provide two different quantification parameters: AMP and the DI (the range of integration is shown in the fig-
ure). The strong positive correlation between AMP and Fe(II)SO4 concentration (b), as well as between DI and Fe(II)SO4 concentration
(c), shows that both parameters are suitable for NO detection. The good correlation between AMP and DI (d) shows that the shape of
the signal does not change. Abbreviations: AMP, amplitude; m, slope; r, coefficient of determination.
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exclusively, whereas nonperfused liver has both NO–Hb
and NO–Fe signals. On this basis, we developed a method
that allows the determination of both paramagnetic signals
in a single EPR spectrum of frozen liver samples.
An important aim of this study was quantification of
the signals. We tested different approaches to create cali-
bration curves for the quantification of NO-related sig-
nals in liver spectra.
In a test tube, we varied concentrations of either natural
NO traps (Hb and Fe2þ) or NO reduced from nitrite (Figs. 2
and 5). We showed that the most feasible way of calibration
is the variation of NO trap (Hb and Fe2þ) concentrations in
the presence of an excess of NO. Using this calibration
method, it was possible to avoid artifacts due to the forma-
tion of complexes other than nitrosyl complexes, as well as
oxidation of NO to other nitrogen species.
Quantification of NO-related signals in blood and liver
of rats after intravenous endotoxin treatment revealed
that the highest NO concentrations occurred in blood of
liver vasculature, the second highest NO levels were
observed in intracellular compartments, and the lowest
concentration was found in circulating blood (Fig. 6).
These data indicate that the liver is an important source
of NO found in circulating blood. It should be noted, how-
ever, that the mesenteric system may also contribute to
elevated NO levels during inflammation (9).
FIG. 6. Quantification of NO formed in cells and in blood upon LPS treatment and characterization of NO pools. The dose of LPS varied
from 0.2 to 7.3 mg/kg body weight. Blood (a) and liver (b) EPR spectra were recorded 16 h after injection of 0.2 (S2, S7), 3.7 (S3, S8),
4.9 (S4, S9), and 8.5 (S5, S10) mg/kg body weight LPS or an equivalent volume of NaCl (S1, S6). NO–Hb in blood (c) and liver (d), as
well as NO–Fe in liver tissue (e) correlated with LPS dose. There was also a good correlation between all these parameters (f–h). Abbre-
viations: m, slope; r, coefficient of determination; S, signal.
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Kupffer cells may be the other substantial source of
NO detectable in blood compartment of the liver (Fig. 7).
In a previous study, we showed that NO is able to dif-
fuse from tissues to blood, but not vice versa (13). These
findings explain the high correlation between NO–Hb
and NO–Fe in nonperfused liver, which was stronger
than the correlation between NO–Hb in blood and liver.
This finding suggests that NO formed in liver cells dif-
fuses into the blood compartment (microvasculature of
liver) and is subsequently bound to Hb.
NO–Hb is present in two forms in mammals: 5-
coordinated and 6-coordinated heme-iron complexes,
which have distinct EPR spectra (14). According to Fink
et al. (15), animal (rodent) NO–Hb exists predominantly
in the 5-coordinated form, whereas human NO–Hb exists
predominantly in 6-coordinated complexes.
In our model, the formation of NO–Hb complexes in
the blood compartment of the liver may be indirectly
confirmed by the fact that NO–Hb complexes in blood
were mostly 6-coordinated (Fig. 6a), whereas the 5-
coordinated form of NO–Hb was more dominant in liver
tissue (Fig. 6b), suggesting that these complexes do not
originate in blood. Therefore, for the evaluation, we
selected a part of the spectrum in which the signals of
both the 5- and 6-coordinated forms were present.
Our data suggest that dinitrosyl–iron complexes scav-
enge only a part of NO formed in cells, whereas the
other part can contribute to physiological NO signaling
and/or diffuse into the blood. This conclusion can be
drawn from a comparison of our data with NO concen-
trations determined in the tissue using the specific NO
trap iron-diethylthiocarbamate in a similar model, where
these values were substantially higher (16).
CONCLUSIONS
The proposed method enables the specific quantification of
intra- and extracellular NO levels in liver biopsies by ana-
lyzing the NO–Hb and NO–Fe signals. These naturally
occurring NO complexes have distinct EPR spectra and act
as endogenous NO traps, wherefore they represent an excel-
lent alternative for the potentially harmful exogenous NO
traps. From our experiments it emerged very clearly that the
NO–Fe complexes detected in liver tissue are formed only
in parenchymal compartment, whereas the NO–Hb com-
plexes detected in both, blood and unperfused liver tissue,
are formed only in blood compartment. This finding
together with the observation that NO–Hb is no longer
detectable in liver tissue after removal of RBCs by tissue
perfusion reinforces the statement that NO–Fe occurs exclu-
sively in parenchymal cells and NO–Hb in blood, empha-
sizing the usage of NO–Fe and NO–Hb signals to
distinguish between intracellular and extracellular NO lev-
els. In addition, the coordination state of NO to Hb, which
is delivered with the same EPR spectra, allows a further dis-
tinction between the NO–Hb complexes formed within liver
and nonliver vasculature. Accordingly, NO–Hb complexes
detected in blood are mainly 6-coordinated, whereas those
detected in liver vasculature are mainly 5-coordinated.
Despite the decrease in sensitivity, the detection method
based on endogenous NO traps has an advantage in that it
interferes less with metabolic pathways of NO. The major
advantage, however, is that it does not require any injection
of NO traps. The latter enables to use this assay in clinical
settings. Thus, our study provides a viable method and
simultaneously underlines the necessity to examine human
biopsies. As a first step, retrospective analysis of samples
kept in the bio banks should be performed.
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SUPPORTING INFORMATION
Additional Supporting Information may be found in the online version of
this article.
Fig. S1. EPR spectra obtained from sham-operated animals (S1) and ani-
mals challenged with 6.3 mg/kg body weight of LPS for 16 h (S2). Both
spectra show the NO–Hb and NO–Fe peaks, which arose at g5 2.075 and
g52.042, respectively. The subtraction of S1 from S2 (S3) led to a
decrease in both peaks, making it more difficult to observe and quantify
them. Abbreviations: g, g-factor; S, signal.
2380 Dumitrescu et al.
